MJ Mansilla

Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration

P. Parizel, F. Prósper, W. van Hecke, 2019, BMJ Open.